The hERG inhibition at 1uM of a compound with the SMILES Cc1cn(-c2cc(NC(=O)c3ccc(C)c(NC(=O)c4cccc(-c5cn[nH]c(=O)c5)c4)c3)cc(C(F)(F)F)c2)cn1.O=C(O)C(F)(F)F is 13.160\%.
The {herg_central_at_1uM__names__noun} of a {#drug|compound!} with the {SMILES__description} {SMILES#} is {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1cn(-c2cc(NC(=O)c3ccc(C)c(NC(=O)c4cccc(-c5cn[nH]c(=O)c5)c4)c3)cc(C(F)(F)F)c2)cn1.O=C(O)C(F)(F)F
Cc1cn(-c2cc(NC(=O)c3ccc(C)c(NC(=O)c4cccc(-c5cn[nH]c(=O)c5)c4)c3)cc(C(F)(F)F)c2)cn1.O=C(O)C(F)(F)F
4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[3-(6-oxo-1H-pyridazin-4-yl)benzoyl]amino]benzamide;2,2,2-trifluoroacetic acid